Ideally, the healthcare industry needs to be more consumer driven, so that solutions and programs are built with the patient in mind, said Jay Sheehy, senior vice president of product innovation at EmblemHealth.
Ideally, the healthcare industry needs to be more consumer driven, so that solutions and programs are built with the patient in mind, said Jay Sheehy, senior vice president of product innovation at EmblemHealth. However, he said that while the industry is on its way there, there is still much work to be done.
Transcript (slightly modified)
Is consumer engagement the same as healthcare consumerism?
I think you could probably argue that both ways. The way I would answer would be going back to the fact that I think in healthcare, we’re still learning what the consumer really wants. Our goal and aspirationally is to be consumer obsessed. If you put the consumer and build everything around them and understand them better, you’re going to be very successful.
But we’re nowhere near that. We’re on a journey to get there. So to me, when you ask about consumerism in healthcare, you talk about consumer-directed programs, they are all different interim strategies to really understand the consumer and get the consumer engaged. And that’s what we’re really trying to learn. And then what you also find out is there are people who are already engaged, there are people who are engageable, and there are people who are never going to be engageable or take accountability. So how do you really deploy strategies and solutions to really address each of those different groups?
Do you actually see healthcare becoming like Amazon? Is it possible?
I think in the industry, we need to strive to be like those companies and understand the consumer well. I think we’re dealing with a far more complicated environment. It’s far more regulated than any of the retail industries but we need to really try to move down that path, maybe not as quickly or as far as some of the true retail companies but that’s the direction you really want to go in because that’s what the consumer expects.
It’s not what we think, it’s really how they want to be dealt with, and how they want to act, and the solutions they’re asking for. So again, we’re dealing with a far more complicated environment but that should not prohibit us from having those aspirational goals to really understand and deliver what they’re really asking for.
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More